Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul 9;21(1):671.
doi: 10.1186/s12879-021-06372-5.

The impact of infectious diseases consultation on the management and outcomes of Pseudomonas aeruginosa bacteraemia in adults: a retrospective cohort study

Fabian Chiong  1 , Mohammed S Wasef  2 , Kwee Chin Liew  3   4 , Raquel Cowan  3 , Danny Tsai  5   6 , Yin Peng Lee  7   8 , Larry Croft  8   9 , Owen Harris  4 , Stella May Gwini  10 , Eugene Athan  3   11
Affiliations

The impact of infectious diseases consultation on the management and outcomes of Pseudomonas aeruginosa bacteraemia in adults: a retrospective cohort study

Fabian Chiong et al. BMC Infect Dis. .

Abstract

Background: Pseudomonas aeruginosa bacteraemia (PAB) is associated with high mortality. The benefits of infectious diseases consultation (IDC) has been demonstrated in Staphylococcal aureus bacteraemia and other complex infections. Impact of IDC in PAB is unclear. This study aimed to evaluate the impact of IDC on the management and outcomes in patients with PAB.

Methods: This is a retrospective cohort single-centre study from 1 November 2006 to 29 May 2019, in all adult patients admitted with first episode of PAB. Data collected included demographics, clinical management and outcomes for PAB and whether IDC occurred. In addition, 29 Pseudomonas aeruginosa (PA) stored isolates were available for Illumina whole genome sequencing to investigate if pathogen factors contributed to the mortality.

Results: A total of 128 cases of PAB were identified, 71% received IDC. Patients who received IDC were less likely to receive inappropriate duration of antibiotic therapy (4.4%; vs 67.6%; p < 0.01), more likely to be de-escalated to oral antibiotic in a timely manner (87.9% vs 40.5%; p < 0.01), undergo removal of infected catheter (27.5% vs 13.5%; p = 0.049) and undergo surgical intervention (20.9% vs 5.4%, p = 0.023) for source control. The overall 30-day all-cause mortality rate was 24.2% and was significantly higher in the no IDC group in both unadjusted (56.8% vs 11.0%, odds ratio [OR] = 10.63, p < 0.001) and adjusted analysis (adjusted OR = 7.84; 95% confidence interval, 2.95-20.86). The genotypic analysis did not reveal any PA genetic features associated with increased mortality between IDC versus no IDC groups.

Conclusion: Patients who received IDC for PAB had lower 30-day mortality, better source control and management was more compliant with guidelines. Further prospective studies are necessary to determine if these results can be validated in other settings.

Keywords: Bacteraemia; Infectious diseases consultation; Mortality; Pseudomonas aeruginosa.

PubMed Disclaimer

Conflict of interest statement

The authors have no competing/conflicting interests to declare in this article.

Figures

Fig. 1
Fig. 1
Kaplan-Meier survival curve showing survival probabilities for patients with Pseudomonas aeruginosa bacteraemia with +IDC and -IDC
Fig. 2
Fig. 2
Antibiogram of Pseudomonas aeruginosa bacteraemia
Fig. 3
Fig. 3
Phylogenetic tree of Pseudomonas species
See this image and copyright information in PMC

References

    1. Bell JM, Gottlieb T, Daley DA, Coombs GW. Australian group on antimicrobial resistance (AGAR) Australian gram-negative Sepsis outcome Programme (GNSOP) annual report 2017. Commun Dis Intell. 2018;2019:43. - PubMed
    1. Kim JM, Park ES, Jeong JS, Kim KM, Kim JM, Oh HS, Yoon SW, Chang HS, Chang KH, Lee SI, Lee MS, Song JH, Kang MW, Park SC, Choe KW, Pai CH. Multicenter surveillance study for nosocomial infections in major hospitals in Korea. Nosocomial infection surveillance Committee of the Korean Society for nosocomial infection control. Am J Infect Control. 2000;28(6):454–458. doi: 10.1067/mic.2000.107592. - DOI - PubMed
    1. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39(3):309–317. doi: 10.1086/421946. - DOI - PubMed
    1. Chatzinikolaou I, Abi-Said D, Bodey GP, Rolston KV, Tarrand JJ, Samonis G. Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer: retrospective analysis of 245 episodes. Arch Intern Med. 2000;160(4):501–509. doi: 10.1001/archinte.160.4.501. - DOI - PubMed
    1. Alikhani MY, Karimi Tabar Z, Mihani F, Kalantar E, Karami P, Sadeghi M, Ahdi Khosroshahi S, Farajnia S. Antimicrobial resistance patterns and prevalence of blaPER-1 and blaVEB-1 genes among ESBL-producing Pseudomonas aeruginosa isolates in west of Iran. Jundishapur J Microbiol. 2014;7(1):e8888. doi: 10.5812/jjm.8888. - DOI - PMC - PubMed

Substances